Adam Biotech retweeted
Beginnings are such delicate times @Adam_Biotech
Adam Biotech retweeted
Getting to see the cool bio startups incubating at MBC BioLabs was so exciting!
We’re excited to bring @Adam_Biotech to the space!
Not just a bioprint.
The most physiologically relevant, reproducible, and viable bioprints.
"Hasn't tissue printing been a thing for 6-7 years?"
Yes, it has. In fact, I've been DOING tissue printing for 6-7 years. What HASN'T existed is knowing WHILE you print whether the tissue you're making is actually viable.
Right now, you print for hours, pull it out, and find out later it failed. That's not a printing problem, that's a bioinfra problem.
Adam Biotech isn't just a new printer. It's also the instrumentation layer that tells you in real time if the print is dying, so you're not wasting days validating garbage.
We're using that layer to give drug researchers the most viable bioprints possible, making it possible to test drugs on 3D models.
Want a bioprint? adambiotech.com
#biotech #startup
As higher throughput methods develop to design and manufacture drugs, higher throughput methods to test and eliminate candidates before expensive in-vivo trials are needed.
Learn more: linkedin.com/feed/update/urn…
Preclinical evaluation isn’t ready for the AI drug boom.
90% entering clinical trials still fail, even after promising preclinical results.
We’re fixing that: 3D-bioprinted human tissues, on demand, built to de-risk your drug.
Visit adambiotech.com
You need vasculature in your bioprinted tissues to print anything larger than a few millimeters. There's many promising routes, such as sacrificial bioprinting.
You can learn more here:
linkedin.com/feed/update/urn…
Human tissue is not gelatinous, but most hydrogels and organoids are. How does one enforce directionality while bioprinting?
Read more: linkedin.com/feed/update/urn…
Adam Biotech retweeted
The new era of drug evaluation starts with better instrumentation.
@Adam_Biotech is excited to reveal what we've been building: a real-time intelligence layer for bioprinting.
More info coming very soon 👀
Before you can bioprint anything, you have to figure out your bioink. A team at Stanford attacked this bottleneck directly. Their printhead combines, mixes, and deposits bioink in programmable ratios.
Read more: linkedin.com/feed/update/urn…
A team at UCSF, led by Dr. Zev Gartner engineered a new support hydrogel that enables researchers to bioprint organoids consistently while enabling cells to self-organize.
Read More: linkedin.com/feed/update/urn…
Adam Biotech retweeted
Brain computing through organoids has a fundamental problem:
Past a certain size, organoids develop a necrotic core where nutrients can’t diffuse into the center. So the cells die.
They’ve tried to fix this by adding blood vessels inside the brain organoid. But these are self-assembling - you can’t place them in specific locations.
So bioprinting is a much more promising solution - Print brain tissue and vascular networks at the same time. The brain tissue can be far larger, be made much faster, and you have control over the placement of each blood vessel and neuron cluster.
Brain organoid computing still sits at the awkward stage where the demos sound like theater and the bottleneck is real enough to be interesting. The JMIR piece on biocomputing names the serious detail. Cortical Labs and FinalSpark are wiring small neural organoids onto multi-electrode arrays, then letting remote researchers stress the tissue with signals, drugs, and feedback loops.
The useful scandal is energy. Silicon scales by making computation cleaner, faster, and more predictable. Biology got good at a different game, learning from noisy scraps while burning almost nothing. If organoid systems remain chaotic, fragile, and ethically annoying, that still does not make them toys. It makes them instruments for discovering what computation looks like before engineering domesticates it.
The correct posture is neither reverence nor panic. Put the tissue on the bench, measure it hard, price the constraints, and let the results embarrass both mystics and regulators.
Adam Biotech retweeted
Replying to @Adam_Biotech
@Adam_Biotech is overjoyed to be incubating at @QB3Berkeley as we continue growing.
There’s no better place to be advancing bioprinting than on the @UCBerkeley campus!
#ucberkeley #biotech #biosciences
Adam Biotech retweeted
Vascularization is why lab-grown organs stay sci-fi.
You can print perfect tissue. Then it dies in hours because nothing’s feeding the cells inside.
Bioprinters can’t see this happening. They print blind and find out it failed hours later.
We’re building the layer that catches it in real time at @Adam_Biotech.
#biotech #bioprinting #drugdiscovery
Adam Biotech was created after our founders got tired of bioprint failure.
Not the kind you catch early. The kind you find out about 6 hrs later when the run is done and the cells are dead.
The data existed but wasn't live.
Real-time monitoring for bioprinters. 🧬
Launching soon.
Contact us at our new & improved website for a pilot or any sort of query:
adambiotech.com















